CA
NZ
UK
AU
IND
US
Central to this disruption has been an intensifying Ukrainian campaign specifically targeting Russian energy infrastructure. Ukraine has reported strikes on an oil depot in the Stavropol region and on storage facilities at the port of Kavkaz, part of a broader strategy aimed at degrading …
Trump announced he was abandoning plans to impose a 20% reimbursement fee on cargo transiting the Strait of Hormuz under US military protection. In place of the fee, Trump indicated the anticipated revenue would instead be replaced by trade and investment commitments from Gulf …
Announcing the change on social media, Trump indicated the anticipated fee revenue would instead be replaced through trade and investment commitments from Gulf states. "I have decided to replace the 20% United States Reimbursement Fee with Trade and Investment Deals that the various Gulf …
A central driver behind the natural gas price weakness is continued growth in domestic supply. Gas output in the Lower 48 states increased to 110.2 billion cubic feet per day in July so far, up from 110.0 bcfd in June, extending a trend of …
At the center of the move, President Trump announced plans to restore a blockade on Iranian vessels passing through the Strait of Hormuz, while also imposing a 20% charge on all other cargo using the waterway. Although this specific fee plan was later replaced …
Trump announced he was abandoning plans to impose a 20% reimbursement fee on cargo passing through the Strait of Hormuz under US military protection, a proposal that had itself been a major source of oil market volatility in recent sessions. In place of the …
The combined entity will operate under the leadership of CEO Dr. Andrew Cheng and will prioritize the development of AVR-001, a long-acting cyclic peptide IL-23 receptor antagonist that Avere has licensed from Hansoh Pharma. The ownership structure of the deal reflects Avere's position as …
PMN310 is designed as a selective antibody targeting toxic amyloid-beta oligomers, a specific and increasingly scrutinized form of the amyloid-beta protein implicated in Alzheimer's disease pathology. Unlike some earlier-generation amyloid-targeting therapies that bind more broadly across various forms of amyloid-beta, including plaque deposits, PMN310's …
The royalty financing arrangement with Healthcare Royalty involves Spero monetizing future milestone payments and sales royalties tied to its approved oral antibiotic, Utebzi, which is currently licensed to GSK. This structure allows Spero to convert what would otherwise be a stream of future, uncertain …
The long-term extension data, drawn from 34 patients with up to 15.9 months of drug exposure, showed a 92% reduction in treated bleeding events, a substantial improvement that speaks to sutacimig's potential to meaningfully reduce the bleeding burden faced by patients with this rare …
Please wait processing your request...